Travere Therapeutics to Report Third Quarter 2025 Financial Results
Go back to Travere Therapeutics to Report Third Quarter 2025 Financial Results| (NASDAQ: TVTX) | Delayed: 66.29 -0.94 (1.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $67.23 | 52 Week High | $ | |||
| Open | $67.18 | 52 Week Low | $ | |||
| Day High | $68.03 | P/E | N/A | |||
| Day Low | $66.13 | EPS | $ | |||
| Volume | 628,958 | |||||

